AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. Nissui Pharmaceutical Co., Ltd.
  3. Financials
  4. Cash and cash equivalents

Nissui Pharmaceutical Co., Ltd.【JP:E00971】

Market cap
P/E ratio
SummaryFinancialsDividendsHistoryWorkforce
Period EndCash and cash equivalents (Million JPY)YoY (%)
Mar 31, 20224,807+7.76%
Mar 31, 20214,461+28.86%
Mar 31, 20203,462+44.19%
Mar 31, 20192,401-68.26%
Mar 31, 20187,565-33.26%
Mar 31, 201711,334+307.08%
Mar 31, 20162,784-8.56%
Mar 31, 20153,045

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)